| pubmed-article:11208685 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0220806 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0002598 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0016385 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0082966 | lld:lifeskim |
| pubmed-article:11208685 | lifeskim:mentions | umls-concept:C0013778 | lld:lifeskim |
| pubmed-article:11208685 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11208685 | pubmed:dateCreated | 2004-7-8 | lld:pubmed |
| pubmed-article:11208685 | pubmed:abstractText | Ibutilide is a class III drug that is used for the cardioversion of atrial arrhythmias, but it can cause torsade de pointes. Amiodarone also prolongs the QT interval but rarely causes torsade de pointes. There are no studies in which the concomitant use of the 2 agents was examined. The purpose of the present study was to assess the efficacy and safety of cardioversion with combination therapy in patients with atrial fibrillation or flutter. | lld:pubmed |
| pubmed-article:11208685 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11208685 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11208685 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11208685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11208685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11208685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11208685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11208685 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11208685 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11208685 | pubmed:issn | 0009-7322 | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:YangYY | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:ChatterjeeKK | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:ChengJJ | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:ScheinmanM... | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:ModisLL | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:KaysenWW | lld:pubmed |
| pubmed-article:11208685 | pubmed:author | pubmed-author:GlatterKK | lld:pubmed |
| pubmed-article:11208685 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11208685 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:11208685 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:11208685 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11208685 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11208685 | pubmed:pagination | 253-7 | lld:pubmed |
| pubmed-article:11208685 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:meshHeading | pubmed-meshheading:11208685... | lld:pubmed |
| pubmed-article:11208685 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11208685 | pubmed:articleTitle | Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. | lld:pubmed |
| pubmed-article:11208685 | pubmed:affiliation | Cardiovascular Research Institute and Section of Cardiac Electrophysiology, University of California, San Francisco 94143-1354, USA. | lld:pubmed |
| pubmed-article:11208685 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11208685 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11208685 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11208685 | lld:pubmed |
